Advertisement
Advertisement

UNCY

UNCY logo

Unicycive Therapeutics, Inc. Common Stock

7.94
USD
Sponsored
+0.08
+1.02%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

8.06

+0.12
+1.51%

Unicycive Therapeutics, Inc. Common Stock Profile

About

Unicycive Therapeutics Inc. is a clinical stage biotechnology company. It involved in developing therapies for patients with kidney disease. The company's lead drug consist Renazorb, is a novel phosphate binding agent being developed for the treatment of hyperphosphatemia. Unicycive Therapeutics Inc. is based in LOS ALTOS, Calif.

Info & Links

CEO

Shalabh Gupta

Headquarters

4300 EL CAMINO REAL, SUITE 210
LOS ALTOS, CA 94022, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.unicycive.com

Auditor

GRASSI & CO., CPAs, P.C.

Share holders

98

Employees

22

Unicycive Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

215.20M

Enterprise Value

186.00M

Enterprise Value/EBITDA(ttm)

-6.43

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.73

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-144.30%

Return on Invested Capital(ttm)

-98.79%

Return on Assets(ttm)

-87.28%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-28.95M

Net Income Available to Common(ttm)

-26.55M

Diluted EPS(ttm)

-2.17

Share Statistics

Beta (5Y Monthly)

1.81

52-Week Change

27.63%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

25.24M

Dividend Yield

0.00%

Float4

22.54M

% Held by Insiders

10.71%

% Held by Institutions

40.42%

Balance Sheet

Total Cash(mrq)

41.27M

Total Cash Per Share(mrq)

1.64

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.59%

Quick Ratio(mrq)

2.59%

Book Value Per Share(mrq)

1.37

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.97

Free Cash Flow(ytd)

-31.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement